2.99
                                            Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Gewinn- und Verlustrechnung
                
            Vierteljährlich
                
            
        *Alle Zahlen in Millionen
    
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 
| Revenues | 
                                            
                                        7.48%
                                     10.84 | 11.71 | 10.44 | 9.0858 | 9.8488 | 
| Cost Of Revenue | 
                                            
                                        41.08%
                                     2.0114 | 1.4257 | 1.9765 | 1.323 | 1.7109 | 
| Gross Profit | 
                                            
                                        14.21%
                                     8.826 | 10.29 | 8.4591 | 7.7628 | 8.1379 | 
|  | 
                                            
                                        6.43%
                                     9.5735 | 8.9954 | 12.28 | 10.78 | 10.88 | 
| Interest Income/Expense | 
                                            
                                        33.12%
                                     0.1095 | 0.1638 | 0.2233 | 0.1374 | 0.1263 | 
| Benefits Costs and Expenses | 
                                            
                                        10.59%
                                     11.57 | 10.46 | 12.34 | 10.62 | 10.95 | 
| Costs And Expenses | 
                                            
                                        11.17%
                                     11.58 | 10.42 | 12.34 | 10.78 | 10.88 | 
| Operating Income/Loss | 
                                            
                                        157.86%
                                     -0.7475 | 1.2919 | -1.842 | -1.6944 | -1.0267 | 
| Income/Loss From Continuing Operations Before Tax | 
                                            
                                        158.18%
                                     -0.7295 | 1.2539 | -1.9016 | -1.5255 | -1.0912 | 
| Income Tax Expense/Benefit | 
                                            
                                        0.02%
                                     0.00567 | 0.00567 | -0.057 | 0.0114 | 0.0114 | 
| Income/Loss From Continuing Operations After Tax | 
                                            
                                        158.90%
                                     -0.7352 | 1.2482 | -1.9016 | -1.537 | -1.1026 | 
|  | 
                                            
                                        158.90%
                                     -0.7352 | 1.2482 | -1.9016 | -1.537 | -1.1026 | 
| Preferred Stock Dividends And Other Adjustments | - | - | - | - | - | 
| Attributable To Noncontrolling Interest | 
                                            
                                        162.28%
                                     0.00553 | -0.00888 | 0.00218 | 0.00711 | -0.017 | 
| Basic Average Shares | 
                                            
                                        0.12%
                                     14.96 | 14.94 | -0.0292 | 14.05 | 14.12 | 
| Diluted Average Shares | 
                                            
                                        1.96%
                                     14.96 | 15.26 | -0.0292 | 14.05 | 14.12 | 
| Basic Earnings Per Share | 
                                            
                                        162.50%
                                     -0.05 | 0.08 | -0.14 | -0.11 | -0.08 | 
| Diluted Earnings Per Share | 
                                            
                                        162.50%
                                     -0.05 | 0.08 | -0.14 | -0.11 | -0.08 | 
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | - | - | - | - | - | 
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App
                